CD86 and neoplasm: Interestingly, data from early lung adenocarcinoma showed that tumour-associated macrophages (TAMs) expressed the immunomodulatory transcription factor PPARγ, CD64, CD14, and CD11c and had reduced expression of CD86 and CD206[21].